June 14 (Reuters) - LAVA Therapeutics NV LVTX.O :
* LAVA THERAPEUTICS PROVIDES UPDATES ON CLINICAL PROGRAMS
AND
EXTENDS THE CASH RUNWAY
* LAVA THERAPEUTICS NV - ASSOCIATED COST SAVINGS AND
INITIATIVES
ARE EXPECTED TO EXTEND CASH RUNWAY FURTHER INTO 2026
* LAVA THERAPEUTICS NV - LAVA-051 PHASE 1/2A CLINICAL TRIAL
WILL
BE DISCONTINUED
* LAVA THERAPEUTICS NV - DECISION TO DISCONTINUE LAVA-051'S
CLINICAL TRIAL FOLLOWS A RECENT REVIEW OF COMPETITIVE LANDSCAPE
THAT HAS CONTINUED TO EVOLVE
Source text for Eikon: ID:nGNXbStjXZ
Further company coverage: LVTX.O
(reuters.briefs@thomsonreuters.com)